Journal of the Peripheral Nervous System

Article	Citations
Abstracts	63
	42
	35
	29
Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study	25
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	22
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	20
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	18
PNS Abstracts 2023	18
	17
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	17
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	16
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	15
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	14
Ofatumumab for treating autoimmune nodopathy	14
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	14
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	14
Issue Information	13
Abstracts of the 35th Annual Meeting of the Japanese Peripheral Nerve Society (JPNS)	13
Feasibility, Validity, and Reliability of the Virtual CMT Infant Toddler Scale (vCMTInfS): A Remote Evaluation of Infants/Toddlers With CMT	13
Variability in Conduction Block Definitions Affects the Sensitivity of Diagnostic Criteria for Multifocal Motor Neuropathy	13
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	12
Assessing corneal dendritic cells in glucose dysregulation small‐fibre neuropathy	12
Effectiveness of exercise therapy for individuals diagnosed with Charcot–Marie–Tooth disease: A systematic review of randomized clinical trials	12
Issue Information	11

Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy	11
A robust framework for characterising diffusion metrics of the median and ulnar nerves: Exploiting state‐of‐the‐art tracking methods	10
Association of dynamic hepatic metabolism with clinical outcomes in patients with severe Guillain‐Barré syndrome: A prospective cohort study from multi‐centers in China	10
Pain hypersensitivity, sensorimotor impairment, and decreased muscle force in a novel rat model of radiation‐induced peripheral neuropathy	10
Parent‐proxy pediatric CMT quality of life outcome measure: Validation of the Italian version	9
Nerve biopsy in acquired neuropathies	9
IgM anti‐MAG± peripheral neuropathy (IMAGiNe) study protocol: An international, observational, prospective registry of patients with IgM M‐protei	9
Techniques for the standard histological and ultrastructural assessment of nerve biopsies	9
Patient‐reported disease burden in the Accelerate Clinical Trials in Charcot–Marie–Tooth Disease Study	9
Issue Information	9
Disease‐specific wearable sensor algorithms for profiling activity, gait, and balance in individuals with Charcot–Marie–Tooth disease type 1A	9
Issue Information	8
Benefit of high‐dose oral riboflavin therapy in riboflavin transporter deficiency	8
Diagnostic and clinical utility of comprehensive multigene panel testing for patients with neuropathy	8
	8
	8
Chronic inflammatory demyelinating polyradiculoneuropathy: Diagnostic problems in clinical practice in Serbia	8
Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis	8
Issue Information	8
Issue Information	8
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	8
Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study (DINE)	7
Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response	7
A novel de novo variant in POLR3B gene associated with a primary axonal involvement of the largest nerve fibers	7
Glucose‐lowering medication associated with weight loss may limit the progression of diabetic neuropathy in type 2 diabetes	7
Issue Information	7
An innovative phase 2 proof‐of‐concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy	7
	7
The autoimmune vulnerability of the node of Ranvier	6
ABSTRACT	6
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	6
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	6
	6
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy	6
INF2 mutations in patients with a broad phenotypic spectrum of Charcot‐Marie‐Tooth disease and focal segmental glomerulosclerosis	5
Digenesis in Charcot–Marie–Tooth Disease: Impact of Combined Mutations in the MFN2 and GDAP1 Genes	5
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	5
	5
Influence of Genomic Ancestry and Other Traditional Risk Factors on the Prevalence of Diabetic Peripheral Neuropathy in Admixed Individuals With Type 1 Diabetes in Brazil: A Pioneer Multicenter Study	5
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy	5
Acquired Transthyretin Amyloidosis in Domino Liver Transplantation Treated With Gene‐Silencers	5
Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin‐related amyloidosis—A Swiss reference center experience	4
High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells	4
GDAP1‐Related Charcot–Marie–Tooth Disease: Axonal or Demyelinating Subtype? Autosomal Recessive or Autosomal Dominant Inheritance?	4
Issue Information	4
Anxiety and depression in small fiber neuropathy	4
Diagnostic value of nerve conduction study in NOTCH2NLC‐related neuronal intranuclear inclusion disease	4
Predicting long‐term trends in inflammatory neuropathy outcome measures using latent class modelling	4
Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post‐hoc analysis of the immunoglobulin overtreatment in CIDP trial	4
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	4

Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?	4
Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study	4
COVID‐19 and the peripheral nervous system. A 2‐year review from the pandemic to the vaccine era	4
Genetic and clinical profile of 15 Chinese families with GDAP1‐related Charcot–Marie–Tooth disease and identification of H256R as a frequent mutation	3
Genetic diversity in hereditary axonal neuropathy: Analyzing 53 Brazilian children	3
Validation of the parent‐proxy version of the pediatric Charcot‐Marie‐Tooth disease quality of life instrument for children aged 0–7 years	3
	3
Cutaneous biomarkers of therapeutic efficacy in early treatment of hereditary ATTR amyloid polyneuropathy with tafamidis	3
Phenotypic features of RETREG1‐related hereditary sensory autonomic neuropathy	3
Earlier diagnosis of peripheral neuropathy in primary care: A call to action	3
Issue Information	3
Issue Information	3
The NCX1 calcium exchanger is implicated in delayed axotomy after peripheral nerve stretch injury	3
Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review	3
Genetic and Clinical Features of 10 Families With Hereditary Sensory Neuropathies	3
The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN‐SIQ): Reply to letter to the Editor	3
Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort	3
Issue Information	3
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus	3
Ultrasound Shear Wave Velocity of Peripheral Nerves: A Possible Non‐Invasive Biomarker for Demyelinating Neuropathies	3
Macrophages influence Schwann cell myelin autophagy after nerve injury and in a model of Charcot‐Marie‐Tooth disease	3
Recent advances in the treatment of Charcot‐Marie‐Tooth neuropathies	3
Focal slowing of nerve conduction velocity in leprosy patients unveiled through multisegmented nerve analysis	3
Issue Information	3
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal	2
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy	2
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients	2
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity	2
Identification of cellular and noncellular components of mature intact human peripheral nerve	2
Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy‐induced peripheral neuropathy	2
Description of a patient cohort with Hereditary Sensory Neuropathy type 1 without retinal disease Macular Telangiectasia type 2 ‐ implications for retinal screening in HSN1	2
Mutational screening of Greek patients with axonal Charcot‐Marie‐Tooth disease using targeted next‐generation sequencing: Clinical and molecular spectrum delineation	2
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor	2
Abstract	2
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves	2
	2
CIDP Treatment Outcomes Correlation With First Nerve Conduction Changes: Ascertainment of Initial and Long‐Term Responders	2
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review	2
Issue Information	2
Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement	2
Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome	2
New Approaches Based on Serial‐Block Face Electron Microscopy to Investigate the Peripheral Nervous System	2
Digital nerve reconstruction with a new composite silk fibroin nerve conduit	2
	2
Etiologic Diagnosis of Neuropathies Based on First‐Line Screening of TTR Gene Mutations	2
Neurological Performance and Clinical Outcomes Related to Patients With Oropouche‐Associated Guillain–Barré Syndrome	2
Advanced Hybrid Closed‐Loop Insulin Delivery Is Associated With Improved Glycemic Indicators and Normalization of Small Nerve Fibre Structure in Adults With Type 1 Diabetes	2
Unusual upper limb features in SORD neuropathy	2
A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease	2
Adult‐onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case report	2
Leptospirosis‐induced acute acquired inflammatory neuropathy	2
Patient‐Reported Outcome Measures for Assessing Health‐Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain‐Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropa	2
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?	2
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla	2
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria	2
Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS)	1
Correction to “Earlier diagnosis of peripheral neuropathy in primary care: A call to action”	1
Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy	1
Abstract	1
Peripheral Neuropathy as an Early Marker in Newborn‐Screened Krabbe Disease: The Value of Pre‐Confirmatory Neurophysiological Testing	1
Issue Information	1
Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies	1
Genetic Deletion of Sarm1 in Mouse Models of Three Neurological Diseases	1
Correction to “Automated immunohistochemistry of intra‐epidermal nerve fibres in skin biopsies: A proof‐of‐concept study”	1
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?	1
Issue Information	1
Issue Information	1
Normal structure and pathological features in peripheral neuropathies	1
Issue Information	1
Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain–Barré Syndrome	1
Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report	1
Intrathecal Antibody Synthesis in Autoimmune Nodopathy	1
Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents	1
Issue Information	1
Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy	1
A 21‐bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course	1
Spontaneous activity of specific C‐nociceptor subtypes from diabetic patients and mice: Involvement of reactive dicarbonyl compounds and (sensitized) transient receptor potential channel A1	1
Variations within Toll‐like receptor (TLR) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome	1
Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape	1
Sural nerve biopsy utility by masked assessment of individual histologic preparations	1

Plasma neurofilament light chain concentrations are elevated in youth‐onset type 2 diabetes and associated with neuropathy	1
Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy	1
Serum neurofilament light chain measurements following nerve trauma	1
Issue Information	1
Monoclonal gammopathy‐associated peripheral neuropathies: Uncovering pearls and challenges	1
	1
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome	1
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A	1
	1
Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy	1
Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response	1
Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review	1
	1
EGR2 gene‐linked hereditary neuropathies present with a bimodal age distribution at symptoms onset	1
B‐cell and T‐cell receptor repertoire in chronic inflammatory demyelinating polyneuropathy, a prospective cohort study	1
	1
Variants of aminoacyl‐tRNA synthetase genes in Charcot‐Marie‐Tooth disease: A Korean cohort study	1
Laura Feltri: In memoriam	1
Altered Cellular Pathways in the Blood of Patients With Guillain‐Barre Syndrome	1